Drugs / Systane Ultra
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06633471 | Nov 2024 → Feb 2025 overdue | dry eye syndrome | PS Therapy Inc. | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00796926 | Jul 2009 → Nov 2010 | blepharitis, xerophthalmia | Louis Tong | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01775540 | May → Oct 2012 | dry eye syndrome | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03524157 Comparator | Jul 2017 → Feb 2018 | allergic disease, dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT03223909 Comparator | Oct 2016 → Oct 2018 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 4 | NCT03183089 Comparator | Dec 2015 → Jan 2016 | dry eye syndrome | The Mentholatum Company | Completed | No outcome recorded |
| Phase 4 | NCT01227226 Comparator | Oct 2010 → Mar 2011 | dry eye syndrome | Hom, Milton M., OD, FAAO | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02558218 Comparator | Jan → May 2015 | cataract | Democritus University of Thrace | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Systane Ultra | “Alcon's Systane Ultra artificial tear” NCT01227226 ↗ |
| Route | Topical | “Used four times a day topically to each eye” NCT00796926 ↗ |